J Epidemiol Community Health

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

J Epidemiol Community Health. Published Online First: 1 May 2008. doi:10.1136/jech.2007.068312
Copyright © 2008 by the BMJ Publishing Group Ltd.

This Article
Free to AccessThis article has been Unlocked
Right arrow Full Text (Rapid PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Clennell, S.
Right arrow Articles by Mishra, G. D
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clennell, S.
Right arrow Articles by Mishra, G. D

RESEARCH REPORTS

Characterisation of smoking behaviour across the life course and its impact on decline in lung function and all-cause mortality: evidence from a British birth cohort

Suzanne Clennell1, Diana L Kuh2, Jack Guralnick3, Kushang Patel3, Gita D Mishra2

1 Medical Research Council National Survey of Health and Developement, United Kingdom;
2 Medical Research Council National Survey of Health and Development, United Kingdom;
3 National Institute on Aging, United States

To whom correspondence should be addressed. E-mail: g.mishra{at}nshd.mrc.ac.uk


ABSTRACT
Objectives To describe smoking trajectories from early adolescence into mid-life, and to examine the effects of these trajectories on health and all-cause mortality.Design A nationally representative birth cohort study.Setting England, Scotland, Wales. Study members 3387 men and women followed up since their birth in 1946.Main outcome measure All-cause mortality by age 60 years, rate of decline in FEV1.

Results Eighteen percent of the sample were categorised as lifelong smokers (smokers at all 6 waves at ages 20, 25, 31, 36, 43, 53 years), of whom 90% had begun smoking by age 18. By age 60, 10% of all lifelong smokers had died. They had a threefold increase in mortality rate compared with never smokers (hazard ratio=3.2, 95%confidence interval:2.1,4.8). For predominantly smokers (smokers for at least four of the six data collections) mortality rate remained higher than never smokers (HR=1.6, 95%CI:1.0,2.5). Predominantly non-smokers did not differ from those who never smoked (HR=1.3, 95%CI:0.9,2.0). Using the most recent smoking status available, current smokers had more than doubled risk of mortality compared with never smokers (HR=2.4, 95%CI:1.6,3.5). Lifelong smokers and predominantly smokers had greater rate of decline in lung function than never-smokers (regression coefficients=-18mL/year, 95%CI:-22,-13; -6, 95%CI: -10.3, -1.7, respectively). For current smokers the decline was 8.4 ml/year (95% CI: -12.0,-5.0) faster than never smokers.

Conclusions: The strength and differentiation of adverse effects identified by using simplified smoking behaviours has highlighted the advantages of obtaining further information on lifelong smoking behaviour from former smokers, rather than just current smoking status.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.